Clinical trial
IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
NCT02847884 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
- Lead sponsor
- University of Alberta
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- June 30, 2018
- Enrollment
- 28 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease, inflammatory bowel disease